BioProject

The project seeks to address a critically important question relating to the acquisition of pathogenic, drug-resistant bacteria by acutely ill hospital patients. More...

The project seeks to address a critically important question relating to the acquisition of pathogenic, drug-resistant bacteria by acutely ill hospital patients. The aim is to define reservoirs and transmission pathways relating to the acquisition of Escherichia coli producing extended-spectrum ?-lactamases (ESBL-EC) in a haematology cohort. The overall approach will be to identify numerous reservoirs of ESBL-EC in a geographically defined area, and use bacterial sequencing combined with mathematical modelling to predict transmission routes between them and the hospital cohort. The hypothesis is that interventions to reduce ESBL-EC carriage and disease in humans are reliant on an understanding of these transmission pathways. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria) please see http://sanger.ac.uk/datasharing/ Less...